BriaCell Therapeutics Corp (BCT) Stock Price, News, Quotes-Moomoo

CA Stock MarketDetailed Quotes

BCT BriaCell Therapeutics Corp

Watchlist

1.190
+0.080+7.21%

15min DelayMarket Closed Aug 23 16:00 ET

21.76MMarket Cap-2333P/E (TTM)

Intraday

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

CREATV BIO ANNOUNCES ITS CAML BIOMARKER INCLUDED IN PIVOTAL PHASE 3 TRIAL IN METASTATIC BREAST CANCER
PR NewswireJul 31 08:00 ET
BriaCell Quadruples Progression Free Survival (PFS) in Patient With "Eye-Bulging" Metastatic Breast Cancer
GlobeNewswireJul 18 07:56 ET
Canada Net Change Percentage Gainers & Losers
Dow JonesJul 2 12:30 ET
10-Q: Q3 2024 Earnings Report
SEC announcementJun 14 16:16 ET · Announcements
Express News | HC Wainwright & Co. Reiterates Buy on BriaCell Therapeutics, Maintains $18 Price Target
BenzingaJun 4 06:54 ET
BriaCell Presents Clinical Efficacy Data at ASCO 2024
GlobeNewswireJun 3 08:00 ET

Comments

Stock Region

Jul 19 19:22

Therapeutics Company Reports Major Progression In Its Phase 2 Study Battling Cancer

BriaCell Quadruples Progression-Free Survival in Metastatic Breast Cancer Patient.
The field of oncology has witnessed numerous advancements over the years, yet metastatic breast cancer continues to pose challenges. However, recent developments reported by BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX: BCT) offer a glimmer of hope. The clinical-stage biotechnology company, known for its innovative immunot...

Heat List

Overall